Clinical Trial

Preliminary Trial of SNA014 for Pancreatic Cancer

Name: Preliminary Trial of SNA014 for Pancreatic Cancer — clinical trial record (NCT07597772)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated May 19, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.

Summary

68Ga labeled Claudin 18.2 contrast agent combined with PET/CT for pancreatic cancer

Trial Details

NCT Number	NCT07597772
Lead Sponsor	SmartNuclide Biopharma Collaborators: Tianjin Medical University Cancer Institute and Hospital
Conditions	Pancreatic Cancer
Enrollment	12 participants
Start Date	2025-10-01
Primary Completion	2026-07-01 (estimated)
Study Completion	2026-07-01 (estimated)
Updated on ClinicalTrials.gov	2026-05-19